PL3353191T3 - Cykliczne polipeptydy, sposób ich pozyskiwania oraz ich zastosowanie terapeutyczne - Google Patents
Cykliczne polipeptydy, sposób ich pozyskiwania oraz ich zastosowanie terapeutyczneInfo
- Publication number
- PL3353191T3 PL3353191T3 PL16794681.3T PL16794681T PL3353191T3 PL 3353191 T3 PL3353191 T3 PL 3353191T3 PL 16794681 T PL16794681 T PL 16794681T PL 3353191 T3 PL3353191 T3 PL 3353191T3
- Authority
- PL
- Poland
- Prior art keywords
- polypeptides
- obtaining
- therapeutic use
- cyclic
- cyclic polypeptides
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 2
- 108090000765 processed proteins & peptides Proteins 0.000 title 2
- 125000004122 cyclic group Chemical group 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1559084A FR3041644B1 (fr) | 2015-09-25 | 2015-09-25 | Polypeptides cycliques, leur procede d'obtention et leur application en therapeutique |
| PCT/FR2016/052422 WO2017051135A1 (fr) | 2015-09-25 | 2016-09-23 | Polypeptides cycliques, leur procede d'obtention et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3353191T3 true PL3353191T3 (pl) | 2023-10-30 |
Family
ID=54545335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16794681.3T PL3353191T3 (pl) | 2015-09-25 | 2016-09-23 | Cykliczne polipeptydy, sposób ich pozyskiwania oraz ich zastosowanie terapeutyczne |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10501497B2 (pl) |
| EP (1) | EP3353191B1 (pl) |
| JP (1) | JP6998878B2 (pl) |
| KR (1) | KR20180050755A (pl) |
| CN (1) | CN108350035A (pl) |
| AU (1) | AU2016328916B2 (pl) |
| CA (1) | CA2999797A1 (pl) |
| DK (1) | DK3353191T3 (pl) |
| ES (1) | ES2952519T3 (pl) |
| FR (1) | FR3041644B1 (pl) |
| PL (1) | PL3353191T3 (pl) |
| WO (1) | WO2017051135A1 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3330284A1 (en) * | 2016-12-05 | 2018-06-06 | Neuronax Sa | Use of peptide compounds for promoting survival, growth and cell differentiation |
| EP3360884A1 (en) | 2017-02-10 | 2018-08-15 | Neuronax | Improved process for the preparation of a dodecapeptide |
| EP4041279A1 (en) | 2019-10-07 | 2022-08-17 | Axoltis Pharma | Systemic administration of peptides for the treatment of spinal cord injury and/or for remyelination |
| CA3159311A1 (en) | 2019-12-05 | 2021-06-10 | Axoltis Pharma | Peptide compositions and methods for treating tauopathies |
| IL309754A (en) | 2021-07-09 | 2024-02-01 | Axoltis Pharma | SCO-SPONDIN-derived polypeptides for enhancing synaptic transmission |
| EP4190347A1 (en) | 2021-12-01 | 2023-06-07 | Axoltis Pharma | Sco-spondin-derived polypeptides for treating biological barriers dysfunction |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69132708T2 (de) * | 1990-09-24 | 2002-06-20 | Philadelphia Health And Education Corp., Philadelphia | Therapeutische Vervendung von Peptiden mit Thrombospondin - ähnlicher Aktivität |
| FR2766190B1 (fr) | 1997-07-16 | 2001-11-02 | Univ Clermont Auvergne | Nouveaux peptides et polypeptides utiles dans la regeneration du systeme nerveux |
| FR2910003B1 (fr) | 2006-12-18 | 2012-10-26 | Neuronax | Nouveaux peptides et polypeptides a stabilite amelioree utiles dans la regeneration du systeme nerveux |
| EP2027868A1 (en) | 2007-08-24 | 2009-02-25 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Use of SCO-Spondin peptides for inhibiting or preventing neuronal apoptosis mediated by cell death receptor ligands |
| JP5476538B2 (ja) * | 2008-03-31 | 2014-04-23 | 学校法人 久留米大学 | 肝疾患に伴う浮腫の判定方法 |
| JP2014101274A (ja) | 2011-03-09 | 2014-06-05 | Jitsubo Co Ltd | 新規な架橋構造を含むｔｎｆレセプターループペプチドの模倣ペプチドを用いた医薬組成物 |
| EP3489396B1 (en) | 2012-12-27 | 2021-03-03 | National Institute of Advanced Industrial Science and Technology | Molecule library constructed on the basis of backbone structure of microprotein |
| JP6363022B2 (ja) | 2013-01-28 | 2018-07-25 | 国立研究開発法人産業技術総合研究所 | 抗体結合性ペプチド |
-
2015
- 2015-09-25 FR FR1559084A patent/FR3041644B1/fr active Active
-
2016
- 2016-09-23 US US15/762,921 patent/US10501497B2/en active Active
- 2016-09-23 JP JP2018535256A patent/JP6998878B2/ja active Active
- 2016-09-23 KR KR1020187011559A patent/KR20180050755A/ko not_active Application Discontinuation
- 2016-09-23 ES ES16794681T patent/ES2952519T3/es active Active
- 2016-09-23 PL PL16794681.3T patent/PL3353191T3/pl unknown
- 2016-09-23 EP EP16794681.3A patent/EP3353191B1/fr active Active
- 2016-09-23 WO PCT/FR2016/052422 patent/WO2017051135A1/fr active Application Filing
- 2016-09-23 CN CN201680062381.3A patent/CN108350035A/zh active Pending
- 2016-09-23 AU AU2016328916A patent/AU2016328916B2/en active Active
- 2016-09-23 CA CA2999797A patent/CA2999797A1/fr active Pending
- 2016-09-23 DK DK16794681.3T patent/DK3353191T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2952519T3 (es) | 2023-10-31 |
| KR20180050755A (ko) | 2018-05-15 |
| FR3041644B1 (fr) | 2018-01-05 |
| US10501497B2 (en) | 2019-12-10 |
| AU2016328916B2 (en) | 2020-08-20 |
| AU2016328916A1 (en) | 2018-04-19 |
| DK3353191T3 (da) | 2023-08-14 |
| EP3353191B1 (fr) | 2023-05-24 |
| US20180265549A1 (en) | 2018-09-20 |
| CA2999797A1 (fr) | 2017-03-30 |
| JP2018531284A (ja) | 2018-10-25 |
| WO2017051135A1 (fr) | 2017-03-30 |
| JP6998878B2 (ja) | 2022-01-18 |
| FR3041644A1 (fr) | 2017-03-31 |
| CN108350035A (zh) | 2018-07-31 |
| EP3353191A1 (fr) | 2018-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1251551A1 (zh) | 氮雜環丁烷衍生物、其製備方法及用途 | |
| PT3546457T (pt) | Derivado de pirazolo-heteroarílico, método de preparação e a utilização médica do mesmo | |
| HK1255566A1 (zh) | 氧代吡啶酰胺類衍生物、其製備方法及其在醫藥上的應用 | |
| HK1232140A1 (zh) | 微類器官以及製造和使用它們的方法 | |
| SG11201608711RA (en) | Material itq-55, method for preparation and use | |
| SG11201607924TA (en) | Figure, platform, and figure system | |
| GB2588261B (en) | Apparatus, use of the apparatus and arrangement | |
| IL262824A (en) | Method, array and their uses | |
| HK1247091A1 (zh) | 治療抗體及其用途 | |
| PL3353191T3 (pl) | Cykliczne polipeptydy, sposób ich pozyskiwania oraz ich zastosowanie terapeutyczne | |
| GB201516801D0 (en) | Method, array and use thereof | |
| PL3157901T3 (pl) | Preparaty, ich wytwarzanie i zastosowanie, oraz odpowiednie składniki | |
| EP3395366C0 (en) | METHOD FOR DESIGNING A DRUG, DRUG OBTAINED AND ASSOCIATED APPLICATION | |
| GB201408673D0 (en) | Medicaments,uses and methods | |
| SG11201703631VA (en) | Novel carbodiimides, method for the production and use thereof | |
| GB201410108D0 (en) | Peptides, and methods and apparatus utilising same | |
| GB201405784D0 (en) | Novel methods, polypeptides and uses thereof | |
| HK1254379A1 (zh) | 烯基苯氧基取代的1，1-二苯基乙烯、它們的製備方法和它們的用途 | |
| HK1252350A1 (zh) | Mrka多肽、抗體及其用途 | |
| HK1251924A1 (zh) | Foxm1衍生的肽和包含它們的疫苗 | |
| ZA201707371B (en) | Cannula device, artificial lung | |
| PL3386988T3 (pl) | Nowe pochodne dihydropiranopirymidynonu i ich zastosowanie | |
| ZA201907335B (en) | Benzothiazole-containing silanes, method for the preparation and use thereof | |
| GB201717345D0 (en) | Peptides, methods and apparatus | |
| HK1251928A1 (zh) | Mphosph1衍生的肽和包括它的疫苗 |